Clivatuzumab (Anti-MUC1)
Clivatuzumab (Anti-MUC1) (A2397-GRP)
Products
Description
Clivatuzumab (Anti-MUC1) is a humanized anti-mucin monoclonal antibody targeting an epitope in the MUC1 antigen expressed in most pancreatic cancers. MW: 145.5 kD.
Specifications
| Manufacturer | Selleck Chemicals LLC |
|---|---|
| Manufacturer Cat# | A2397 |
| Target | Immunology & Inflammation related |